- Home
- GLPG vs ARCB Comparison
GLPG vs ARCB Comparison
Compare GLPG & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- ARCB
- Stock Information
- Founded
- GLPG 1999
- ARCB 1923
- Country
- GLPG Belgium
- ARCB United States
- Employees
- GLPG N/A
- ARCB N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- ARCB Trucking Freight/Courier Services
- Sector
- GLPG Health Care
- ARCB Industrials
- Exchange
- GLPG Nasdaq
- ARCB Nasdaq
- Market Cap
- GLPG 1.8B
- ARCB 1.4B
- IPO Year
- GLPG 2005
- ARCB N/A
- Fundamental
- Price
- GLPG $26.86
- ARCB $67.79
- Analyst Decision
- GLPG Sell
- ARCB Buy
- Analyst Count
- GLPG 4
- ARCB 13
- Target Price
- GLPG $25.33
- ARCB $92.25
- AVG Volume (30 Days)
- GLPG 489.3K
- ARCB 460.2K
- Earning Date
- GLPG 04-23-2025
- ARCB 04-29-2025
- Dividend Yield
- GLPG N/A
- ARCB 0.70%
- EPS Growth
- GLPG N/A
- ARCB 50.16
- EPS
- GLPG N/A
- ARCB 7.55
- Revenue
- GLPG $311,493,731.00
- ARCB $4,109,676,999.00
- Revenue This Year
- GLPG $0.78
- ARCB $0.31
- Revenue Next Year
- GLPG N/A
- ARCB $6.11
- P/E Ratio
- GLPG N/A
- ARCB $9.04
- Revenue Growth
- GLPG 18.32
- ARCB N/A
- 52 Week Low
- GLPG $22.36
- ARCB $55.19
- 52 Week High
- GLPG $31.23
- ARCB $129.83
- Technical
- Relative Strength Index (RSI)
- GLPG 58.65
- ARCB 55.36
- Support Level
- GLPG $24.74
- ARCB $58.16
- Resistance Level
- GLPG $27.81
- ARCB $72.24
- Average True Range (ATR)
- GLPG 0.78
- ARCB 2.80
- MACD
- GLPG 0.00
- ARCB 1.65
- Stochastic Oscillator
- GLPG 69.06
- ARCB 73.90
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.
About ARCB ArcBest Corporation
ArcBest Corp is engaged in logistics operations. The company operates in two operating segments, The Asset-Based segment includes the results of operations of ABF Freight System, Inc. and certain other subsidiaries. The segment operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed LTL services. The services including freight transportation related to managed transportation solutions and other services. The Asset-Light segment includes the results of operations of the Company's service offerings in truckload, ground expedite, dedicated, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.